DrugDashboards

Verapamil Hydrochloride

verapamil hydrochloride · VERAPAMIL HYDROCHLORIDE 180 mg/1 · Capsule, Delayed Release · Oral · Wilshire Pharmaceuticals, Inc.

NDC 52536-0882-01 · 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC · NDA AUTHORIZED GENERIC · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has jumped 32% in a year, to $1.42 per unit — sharp rises like this often mean supply is already tightening. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00$3.00Feb 2025Sep 2026$1.42
20 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$42.46
#90 count
$127.38

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$98,423
1,392 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for verapamil hydrochloride (oral solid) in the next 90 days

sole-source market · price up 7% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
NDA019614
TE code
AB
Approval date
May 29, 1990
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of verapamil hydrochloride (Capsule, Delayed Release)

LabelerStrengthFirst seenLast seen
Wilshire Pharmaceuticals, Inc.VERAPAMIL HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Wilshire Pharmaceuticals, Inc.VERAPAMIL HYDROCHLORIDE 180 mg/1Jul 15, 2026Sep 2, 2026
Wilshire Pharmaceuticals, Inc.VERAPAMIL HYDROCHLORIDE 240 mg/1Jul 15, 2026Sep 2, 2026
Wilshire Pharmaceuticals, Inc.VERAPAMIL HYDROCHLORIDE 360 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Verapamil Hydrochloride — NDC 52536-0882-01," retrieved September 3, 2026, https://drugdashboards.com/drug/52536088201.

Free to cite with attribution — see how the data is put together.